Long-Acting Lenacapavir and Cabotegravir and Viral Suppression Among People With HIV - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Viral Suppression in People With HIV Receiving Long-Acting Lenacapavir or Cabotegravir

  • By

  • Nathanael L. Gistand

  • Ishaan C. Mishra

  • Kyle Hunter

  • Megan J. Heise

  • Chesa Cox

  • Janet Grochowski

  • Francis Mayorga-Munoz

  • Jon Oskarsson

  • Mary Shiels

  • Matthew A. Spinelli

  • Monica Gandhi

  • October 8, 2026

Share

Original Source(s)

Related Content